Literature DB >> 12906856

Characterization of expression at the human XIST locus in somatic, embryonal carcinoma, and transgenic cell lines.

Jennifer C Chow1, Lisa L Hall, Christine M Clemson, Jeanne B Lawrence, Carolyn J Brown.   

Abstract

X inactivation requires XIST, a functional RNA that is expressed exclusively from, and localizes to, the inactive X in female somatic cells. In mouse, low-level unstable transcription of Xist is observed prior to the time of inactivation, and an antisense transcript, Tsix, is a critical regulator of early Xist expression. To examine the presence and impact of an antisense transcript in humans we have characterized the extent of sense and antisense transcription in human somatic, transgenic, and embryonal carcinoma (EC) cell lines. Downstream antisense expression at the human XIST locus was not detected in somatic cells, but was detected in the EC line N-Tera2D1 and in somatic cells with an ectopic XIST locus. Presence of the antisense did not disrupt the stability or localization of the sense transcript. We have also identified additional sense transcripts in EC and female somatic cells and demonstrate that the 5' flanking JPX/ENOX gene is expressed from both the active and the inactive X chromosome in somatic cell hybrids, delimiting the extent of inactive X-specific transcriptional control in somatic cells. These analyses reveal similarities to and differences from the murine Xist and Tsix transcripts and generate a complex picture of developmentally regulated transcription through the region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906856     DOI: 10.1016/s0888-7543(03)00170-8

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  26 in total

Review 1.  Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control.

Authors:  Jeannie T Lee
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

Review 2.  Monoallelic gene expression in mammals.

Authors:  Irina S Zakharova; Alexander I Shevchenko; Suren M Zakian
Journal:  Chromosoma       Date:  2009-02-26       Impact factor: 4.316

3.  Jpx RNA activates Xist by evicting CTCF.

Authors:  Sha Sun; Brian C Del Rosario; Attila Szanto; Yuya Ogawa; Yesu Jeon; Jeannie T Lee
Journal:  Cell       Date:  2013-06-20       Impact factor: 41.582

Review 4.  Enjoy the silence: X-chromosome inactivation diversity in somatic cells.

Authors:  Isabel Sierra; Montserrat C Anguera
Journal:  Curr Opin Genet Dev       Date:  2019-05-17       Impact factor: 5.578

Review 5.  The X chromosome in space.

Authors:  Teddy Jégu; Eric Aeby; Jeannie T Lee
Journal:  Nat Rev Genet       Date:  2017-05-08       Impact factor: 53.242

Review 6.  XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome.

Authors:  L L Hall; J B Lawrence
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-03-29

Review 7.  The architectural organization of human stem cell cycle regulatory machinery.

Authors:  Gary S Stein; Janet L Stein; Andre van J Wijnen; Jane B Lian; Martin Montecino; Ricardo Medina; Kristie Kapinas; Prachi Ghule; Rodrigo Grandy; Sayyed K Zaidi; Klaus A Becker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

8.  Expression of X-linked genes in deceased neonates and surviving cloned female piglets.

Authors:  Le Jiang; Liangxue Lai; Melissa Samuel; Randall S Prather; Xiangzhong Yang; X Cindy Tian
Journal:  Mol Reprod Dev       Date:  2008-02       Impact factor: 2.609

9.  X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected.

Authors:  Lisa L Hall; Meg Byron; John Butler; Klaus A Becker; Angel Nelson; Michal Amit; Joseph Itskovitz-Eldor; Janet Stein; Gary Stein; Carol Ware; Jeanne B Lawrence
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

10.  Identification of regulatory elements flanking human XIST reveals species differences.

Authors:  Samuel C Chang; Carolyn J Brown
Journal:  BMC Mol Biol       Date:  2010-03-08       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.